Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (9): 9-14.doi: 10.6040/j.issn.1671-7554.0.2021.0936

Previous Articles     Next Articles

Targeting angiogenesis for disease therapy

CAO Yihai   

  1. Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm 171 65, Sweden
  • Published:2021-10-15

RichHTML

32

PDF (PC)

388

Abstract: Angiogenesis, the process of new blood vessel growth, is involved in the onset, development and progression of a number of human diseases, including the most common and lethal disorders such as cardiovascular disease, cancer, diabetes, inflammatory disease, and eye disease. Interference of angiogenesis by either enhancement or suppression provides exciting and important therapeutic approaches for treatment of these and other diseases. So far, a number of drugs targeting angiogenesis have received approvals from the FDA authorities in various countries for treatment of malignant and ophthalmological diseases. This article aims to provide mechanistic insights into angiogenesis in diseases, new therapeutic options, and therapeutically challenging issues in the clinic.

Key words: Angiogenesis, Cancer, Eye disease, Cerebrocardiovascular disease, Metabolic disease, COVID-19

CLC Number: 

  • R732.2
[1] Folkman J. Tumor angiogenesis: therapeutic implications [J]. N Engl J Med, 1971, 285(21): 1182-1186.
[2] Cao Y. Off-tumor target - beneficial site for antiangiogenic cancer therapy? [J]. Nat Rev Clin Oncol, 2010, 7(10): 604-608.
[3] Cao Y. VEGF-targeted cancer therapeutics-paradoxical effects in endocrine organs [J]. Nat Rev Endocrinol, 2014, 10(9): 530-539.
[4] Cao Y, Arbiser J, DAmato RJ, et al. Forty-year journey of angiogenesis translational research [J]. Sci Transl Med, 2011, 3(114): 114rv113. doi: 10.1126/scitranslmed.3003149.
[5] Cao Y, Langer R. Optimizing the delivery of cancer drugs that block angiogenesis [J]. Sci Transl Med, 2010, 2(15): 15ps13. doi: 10.1126/scitranslmed.3000399.
[6] Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors [J]. Nat Med, 2003, 9(6): 669-676.
[7] Cao Y. Positive and negative modulation of angiogenesis by VEGFR1 ligands [J]. Science signaling, 2009, 2(59): re1. doi: 10.1126/scisignal.259re1.
[8] Cao Y, Linden P, Farnebo J. et al. Vascular endothelial growth factor C induces angiogenesis in vivo [J]. Proc Natl Acad Sci USA, 1998, 95(24): 14389-14394.
[9] Joukov V, Sorsa T, Kumar V, et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C [J]. EMBO J, 1997, 16(13): 3898-3911.
[10] Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J]. Nature, 1996, 380(6573): 439-442.
[11] Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J]. Nature, 1996, 380(6573): 435-439.
[12] OReilly MS, Holmgren L, Chen C, et al. Angiostatin induces and sustains dormancy of human primary tumors in mice [J]. Nature medicine, 1996, 2(6): 689-692.
[13] Cao Y, OReilly MS, Marshall B, et al. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases [J]. J Clin Invest, 1998, 101(5): 1055-1063.
[14] Gimbrone Jr MA, Leapman SB, Cotran RS, et al. Tumor dormancy in vivo by prevention of neovascularization [J]. J Exp Med, 1972, 136(2): 261-276.
[15] Folkman J. Tumor angiogenesis and tissue factor [J]. Nature medicine, 1996, 2(1996): 167-168.
[16] Senger DR, Galli SJ, Dvorak AM, et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid [J]. Science, 1983, 219(4587): 983-985.
[17] Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen [J]. Science, 1989, 246(4935): 1306-1309.
[18] Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J]. N Engl J Med, 2004, 350(23):2335-2342.
[19] Van Cutsem E, Sagaert X, Topal B, et al. Gastric cancer [J]. Lancet, 2016, 388(10060): 2654-2664.
[20] Garon EB, Ciuleanu TE, Arrieta O, et al. Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy(REVEL): a multicentre, double-blind, randomised phase 3 trial [J]. Lancet, 2014, 384(9944): 665-673.
[21] Cao Y. Obesity Protects Cancer from Drugs Targeting Blood Vessels [J]. Cell Metab, 2018, 27(6): 1163-1165.
[22] Iwamoto H, Abe M, Yang Y, et al. Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance [J]. Cell Metab, 2018, 28(1): 104-117.
[23] OReilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth [J]. Cell, 1997, 88(2): 277-285.
[24] OReilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma [J]. Cell, 1994, 79(2): 315-328.
[25] Li Y, Huang P, Peng H, et al. Antitumor effects of Endostar(rh-endostatin)combined with gemcitabine in different administration sequences to treat Lewis lung carcinoma [J]. Cancer Manag Res, 2019, 11: 3469-3479. doi: 10.2147/CMAR.S192868. eCollection 2019.
[26] Ferrara N, Adamis AP. Ten years of anti-vascular endothelial growth factor therapy [J]. Nat Rev Drug Discov, 2016, 15(6): 385-403.
[27] Adamis AP, Ehrlich J, Fung A. Targeting the Effect of VEGF in Diabetic Macular Edema [J]. N Engl J Med, 2015, 373(5): 480-481.
[28] DAmico DJ, Masonson HN, Manju Patel, et al. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials [J]. Ophthalmology, 2006, 113(6): 992-1001.
[29] Arany Z, Foo SY, Ma Y, et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha [J]. Nature, 2008, 451(7181): 1008-1012.
[30] Makino Y, Cao R, Svensson K, et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression [J]. Nature, 2001, 414(6863): 550-554.
[31] LeCouter J, Kowalski J, Foster J, et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium [J]. Nature, 2001, 412(6850): 877-884.
[32] Gragoudas ES, Adamis AP, Cunningham Jr ET, et al. Pegaptanib for neovascular age-related macular degeneration [J]. N Engl J Med, 2004, 351(27): 2805-2816.
[33] Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration [J]. N Engl J Med, 2006, 355(14): 1432-1444.
[34] Dixon JA, Oliver SC, Olson JL, et al. VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration [J]. Expert Opin Investig Drugs, 2009, 18(10): 1573-1580.
[35] Wells JA, Glassman AR, Ayalaet AR, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema [J]. N Engl J Med, 2015, 372(13): 1193-1203.
[36] Rosenfeld PJ. Bevacizumab versus ranibizumab for AMD [J]. N Engl J Med, 2011, 364(20): 1966-1967.
[37] Kim SY, Yoon MH, Chin HS. Changes in the ganglion cell-inner plexiform layer after consecutive intravitreal injections of anti-vascular endothelial growth factor in age-related macular degeneration patients [J]. Korean J Ophthalmol, 2020, 34(1): 11-18.
[38] Filek R, Hooper P, Sheidow TG, et al. Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients [J]. Clin Ophthalmol, 2019, 13: 1087-1096. doi: 10.2147/OPTH.S199758. eCollection 2019.
[39] Cao R, Xue Y, Hedlund EM, et al. VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy [J]. Proc Natl Acad Sci USA, 2010, 107(2): 856-861.
[40] Saint-Geniez M, Maharaj AS, Walshe TE, et al. Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors [J]. PLoS One, 2008, 3(11): e3554. doi: 10.1371/journal.pone.0003554.
[41] Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease [J]. Nat Med, 1995, 1(1): 27-31.
[42] Cao R, Brakenhielm E, Pawliuk R, et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2 [J]. Nat Med, 2003, 9(5): 604-613.
[43] Lu H, Xu X, Zhang M, et al. Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs [J]. Proc Natl Acad Sci USA, 2007, 104(29): 12140-12145.
[44] Rees RS, Robson MC, Smiell JM, et al. Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study [J]. Wound Repair Regen, 1999, 7(3): 141-147.
[45] Rupnick MA, Panigrahy D, Zhang CY, et al. Adipose tissue mass can be regulated through the vasculature [J]. Proc Natl Acad Sci USA, 2002, 99(16): 10730-10735.
[46] Brakenhielm E, Cao R, Gao B, et al. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice [J]. Circ Res, 2004, 94(12): 1579-1588.
[47] Cao Y. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases [J]. Nat Rev Drug Discov, 2010, 9(2): 107-115.
[48] Cao Y. Angiogenesis modulates adipogenesis and obesity [J]. J Clin Invest, 2007, 117(9): 2362-2368.
[49] Cao Y. Angiogenesis and vascular functions in modulation of obesity, adipose metabolism, and insulin sensitivity [J]. Cell Metab, 2013, 18(4): 478-489.
[50] Xue Y, Petrovic N, Cao R, et al. Hypoxia-independent angiogenesis in adipose tissues during cold acclimation [J]. Cell Metab, 2009, 9(1): 99-109.
[51] Seki T, Hosaka K, Lim S, et al. Endothelial PDGF-CC regulates angiogenesis-dependent thermogenesis in beige fat [J]. Nat Commun, 2016, 7: 12152. doi: 10.1038/ncomms12152.
[52] Fischer C, Seki T, Lim S, et al. A miR-327-FGF10-FGFR2-mediated autocrine signaling mechanism controls white fat browning [J]. Nat Commun, 2017, 8(1): 2079. doi: 10.1038/s41467-017-02158-z.
[53] De Benedetti F, Brunner HI, Ruperto N, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis [J]. N Engl J Med, 2012, 367(25): 2385-2395.
[54] Tindall EA, Fox DA. Treatment for rheumatic disorders [J]. N Engl J Med, 2006, 354(12): 1322-1323.
[55] Dinarello CA. Interleukin-1beta and the autoinflammatory diseases [J]. N Engl J Med, 2009, 360(23): 2467-2470.
[56] Chan FK, Hung LC, Suen BY, et al. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis [J]. N Engl J Med, 2002, 347(26): 2104-2110.
[57] Pang J, Xu F, Aondio G, et al. Efficacy and tolerability of bevacizumab in patients with severe Covid-19 [J]. Nat Commun, 2021, 12(1): 814. doi: 10.1038/s41467-021-21085-8.
[1] YU De-Xin, CAEI Ti-Gong, MA Xiang-Xing, ZHANG Xiao-Ming, LI Chuan-Fu. Angiogenesis and maturation of hepatocellular carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 51-54.
[2] HAN Jing, JIA Chunling. Effects of periodontal basic therapy on postoperative pneumonia in patients with lung cancer before thoracic surgery [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 113-118.
[3] Qun LU,Lulu ZHAO. Progress on assisted reproductive technology for women with atypical endometrial hyperplasia and endometrial carcinoma receiving fertilitysparing treatment [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 35-41.
[4] Ruifang WU,Changzhong LI. Status and progress of female fertility protection [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 1-7.
[5] Yun LIN,Yanqiu XIE. Fertility protection and preservation in breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 42-46.
[6] ZHANG Zhenwei, LI Jia, CHEN Keming. IGF2BP2/m6A/ITGA5 signal axis regulates the proliferation and migration of renal clear cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 74-84.
[7] XU Xiaofen, ZHU Xiao, MA Wei, LI Na. Influencing factors of cancer pain management disorder in 123 cancer patients [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 119-124.
[8] HE Shiqing, LI Wanwan, DONG Shuqing, MOU Jingyi, LIU Yuying, WEI Siyu, LIU Zhao, ZHANG Jiaxin. Construction of a prognostic risk model of pyroptosis-related genes in breast cancer based on database [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 34-43.
[9] Qifeng YANG,Ning ZHANG. Sentinel lymph node biopsy of breast cancer in the era of precision medicine [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 1-5.
[10] GAO Zhongxia, ZHANG Ming, FAN Mingde, TAN Chenyang, WANG Mengdi, WANG Chao, FAN Yuefei, DING Shouluan, WANG Chengwei. Efficacy and prognostic factors of gamma knife in treating 81 cases of brain metastases from lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 44-49.
[11] FU Jia, WANG Lulu, HU Shuai, CHEN Zheping, LIU Dongyi, LI Qingsong, LU Guodong, ZHANG He, ZHAO Xin, FENG Chang. Effects of different approaches of quadrates lumborum block on postoperative recovery of patients undergoing radical gastrectomy [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 50-57.
[12] WU Xinying, FENG Yiping, CHANG Kaifeng, JIA Xianjie, XUE Fuzhong. Causal association between green space and cancer incidence [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 115-119.
[13] QIN Jing, YANG Fei, CHEN Qian, XIA Handai, LIU Yanguo, WANG Xiuwen. A network meta-analysis of first-line treatment options for patients with advanced driver-gene wild-type and PD-L1 negative non-squamous non-small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 74-82.
[14] WANG Fuli, SUN Yinping, QIN Jie, RONG Jiansheng. Efficacy of DC-CIK cells combined with EGFR-TKI for 35 elderly patients with advanced EGFR-mutant lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 110-117.
[15] SUN Haoyu, JIANG Xin, CHEN Shouzhen, QU Sifeng, SHI Benkang. Multiparametric magnetic resonance imaging combined with prostate health index in the diagnosis of prostate cancer in 142 patients within PSA grey zone [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 46-50.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] LYU Longfei, LI Lin, LI Shuhai, QI Lei, LU Ming, CHENG Chuanle, TIAN Hui. Application of laparoscopic fine needle catheter jejunostomy in minimally invasive McKeown resection of esophageal cancer[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 77 -81 .
[2] SHAO Haigang, WANG Xuan, WANG Qing. Anatomy of the root canal system of mandibular first premolar in population of Shandong Province[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(9): 85 -89 .
[3] TANG Fang1,2, ZHANG Yingqian3, WANG Zhiqiang4, KANG Dianmin4,
WANG Jiezhen1, XUE Fuzhong1. A 2D minimal spanning tree model of the spatial structures of natural focal disease[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(01): 106 -110 .
[4] SHI Shuang, LI Juan, MI Qi, WANG Yunshan, DU Lutao, WANG Chuanxin. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 47 -52 .
[5] LI Yu-liang,WANG Yong-zheng,WANG Xiao-hua,ZHANG Fu-jun,ZHU Li-dong,ZHANG Wang-ming,LI Zheng,LI Zhen-jia,ZHANG Kai-xian. I implantation combined with Gemcitabine in the treatment of advanced pancreatic cancer[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(4): 393 -396 .
[6] ZHU Xiaoli1, GUO Shuling1, SU Lei1, FENG Yuxin2, YUAN Fangshu1. Extraction of total proteins from demodex and qualification of their molecular weights[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(5): 58 -62 .
[7] HUANG Fei,WANG Huaijing,XING Yi,GAO Wei,LI Yonggang,XING Ziying,LI Zhenzhong. Protective effects of NGF and GM1 on primary sensory neurons in SD rat with sciatic nerve injury[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(4): 332 -335 .
[8] WANG Xiaoju1，　WANG Mingming2，　XU Wansu2,　ZHAO Shengmei3，CUI Sunan2，　LI Xiaoying2，　LIU Chunhua1
. Expression of peripheral blood lymphocyte ubiquitin mRNA in chronic HBV infection with active inflammation and its clinical significance[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(02): 58 -61 .
[9] ZHONG Nv-juan1, SONG Yong-mei2, LIU Gengsheng2, XUE Fu-zhong1, LIU Yan-xun1. Construction and application of the Bayes network model in
traditional Chinese medicine elements[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 157 .
[10] LIU Hai-Chun, ZHANG Jian-Feng, CHEN Yuan-zhen. Bone collagen and biomechanical propertyies in the femur of osteoporosis rats[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(5): 42 -45 .
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd